ArticleFrontiers in pharmacology2021
Adherence and Associated Factors of Treatment Regimen in Drug-Susceptible Tuberculosis Patients.
Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 3 syntheses or guidelines pooled it, 63 citations in OpenAlex.
- Barriers to and enablers of adherence to the treatment of active drug-sensitive tuberculosis in people living with HIV: a mixed method systematic review.BMC public health · 2025Pooled it
- Effect of calcium-channel blockers on the risk of active tuberculosis and mortality: systematic review and meta-analysis.Frontiers in pharmacology · 2024Pooled it
- Prevalence and predictive factors of tuberculosis treatment interruption in the Asia region: a systematic review and meta-analysis.BMJ global health · 2023Pooled it
- Synthesis and evaluation of novel 3,5-dinitrobenzoyl substituted amino acid hydrazides againstRSC medicinal chemistry · 2026Article
- Treatment outcomes and risk factors for unfavorable results among older asymptomatic pulmonary tuberculosis patients in China, 2021-2024.BMC geriatrics · 2026Article
- Barriers to treatment completion among drug-sensitive tuberculosis patients: evidence from Indonesia's tuberculosis surveillance system.Osong public health and research perspectives · 2026Article
- Common Adverse Reactions and Management Strategies of First-Line Anti-Tuberculosis Drugs.Infection and drug resistance · 2026Review
- The Feasibility of Implementing Interprofessional Collaboration-Based Telecare Services for Patients With Tuberculosis: A Mixed Methods Study From Hospital Insight.Interdisciplinary perspectives on infectious diseases · 2026Article
- Drug-resistant TB treatment outcomes and factors associated with discontinuation and LTFU in Germany: No1Lost study protocol.IJTLD open · 2026Article
- A cost-effectiveness evaluation of methods for screening for TB infection in patients with diabetes mellitus.IJTLD open · 2025Article
- Article
- Structural model of determinants of medication adherence in elderly individuals with tuberculosis in Iran.BMC public health · 2025Article
- Medication adherence in patients with nontuberculous mycobacterial disease.Journal of clinical tuberculosis and other mycobacterial diseases · 2025Article
- [Eighty-four Years of the Masan National Tuberculosis Hospital: The Journey to Eliminate Tuberculosis and New Challenges Ahead].Jugan geon-gang gwa jilbyeong · 2025Article
- Trends, prevalence, and determinants of unfavorable tuberculosis treatment outcomes among adult patients in Northeast Ethiopia: The race to achieve a 90 % treatment success rate by 2025.Global epidemiology · 2025Article
- Observational
- Revolutionizing tuberculosis treatment: Breakthroughs, challenges, and hope on the horizon.Acta pharmaceutica Sinica. B · 2025Review
- Fabrication and optimization of freeze-dried isoniazid-loaded poly-ADMET & DMPK · 2025Article
- Predicting treatment adherence in patients with drug-resistant tuberculosis: insights from socioeconomic, demographic, and clinical factors of patients in the rural Eastern Cape.Frontiers in tuberculosis · 2025Article
- Integrating socio-economic support into drug-resistant TB care to optimise treatment outcomes.IJTLD open · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.